Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (11-20 of 368) with videos related to

Pageof 37
Sort By:
International Journal of Cardiology|April 21, 2023
SGLT 2 inhibitors: Searching for the best in classCarlos Escobar, Vivencio Barrios
Expert Opinion on Pharmacotherapy|November 22, 2012
New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatranVivencio Barrios, Carlos Escobar
Integrated Blood Pressure Control|September 28, 2011
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utilityVivencio Barrios, Carlos Escobar
Circulation|June 19, 2013
Letter from Barrios and Escobar regarding article, "trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national health and nutrition examination survey, 2001 to 2010"Vivencio Barrios, Carlos Escobar
Medicina Clinica|June 8, 2013
[Atrial fibrillation in clinical practice: more answers are required]Vivencio Barrios, Carlos Escobar
Lancet (London, England)|June 11, 2013
Obesity, blood pressure, and cardiovascular outcomesVivencio Barrios, Carlos Escobar
Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Hypertension and children: should we be aware?Vivencio Barrios, Carlos Escobar
The Journal of Emergency Medicine|November 9, 2013
Dabigatran and bleeding risk: the importance of a correct prescriptionCarlos Escobar, Vivencio Barrios
Future Cardiology|April 29, 2016
Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practiceVivencio Barrios, Carlos Escobar
Journal of Hypertension|June 3, 2016
Blood pressure goals revisitedVivencio Barrios, Carlos Escobar
Pageof 37

Showing results (11-20 of 368) with videos related to

Sort By:
Pageof 37
International Journal of Cardiology|April 21, 2023
SGLT 2 inhibitors: Searching for the best in classCarlos Escobar, Vivencio Barrios
Expert Opinion on Pharmacotherapy|November 22, 2012
New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatranVivencio Barrios, Carlos Escobar
Integrated Blood Pressure Control|September 28, 2011
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utilityVivencio Barrios, Carlos Escobar
Circulation|June 19, 2013
Letter from Barrios and Escobar regarding article, "trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national health and nutrition examination survey, 2001 to 2010"Vivencio Barrios, Carlos Escobar
Medicina Clinica|June 8, 2013
[Atrial fibrillation in clinical practice: more answers are required]Vivencio Barrios, Carlos Escobar
Lancet (London, England)|June 11, 2013
Obesity, blood pressure, and cardiovascular outcomesVivencio Barrios, Carlos Escobar
Hypertension (Dallas, Tex. : 1979)|October 16, 2013
Hypertension and children: should we be aware?Vivencio Barrios, Carlos Escobar
The Journal of Emergency Medicine|November 9, 2013
Dabigatran and bleeding risk: the importance of a correct prescriptionCarlos Escobar, Vivencio Barrios
Future Cardiology|April 29, 2016
Implications of edoxaban in the prevention and treatment of thromboembolic complications in clinical practiceVivencio Barrios, Carlos Escobar
Journal of Hypertension|June 3, 2016
Blood pressure goals revisitedVivencio Barrios, Carlos Escobar
Pageof 37